Linear Antimicrobial Peptide, Containing a Diindolyl Methane Unnatural Amino Acid, Potentiates Gentamicin Against Methicillin‐Resistant Staphylococcus aureus
Drug Development Research · 2025
DOI: 10.1002/ddr.70070 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Development Research, 2025. Verfasst von Shalini Singh und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Indian Institute of Technology Kanpur, Kanpur, India. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Gentamicins, Anti-Bacterial Agents, Amino Acids. Die Arbeit nennt 51 Literaturangaben. Gefördert von: This research was supported by Center of Excellence in Antimicrobial Resistance, Department of Science and Technology, Ministry of Science and Technology, Indi….
Abstract (Originalsprache)
The headway for the management of emerging resistant microbial strains has become a demanding task. Over the years, antimicrobial peptides (AMP), have been recognized and explored for their highly systematized SAR and antibacterial properties. With this background, we have reported a new class of AMPs. These peptides incorporate an unnatural amino acid, with a motivation from cruciferous bioactive phytochemical bisindoles methane derivatives with highly selective antimicrobial action. These peptides may also be considered as linear derivatives of hirsutide isolated from entomopathogenic fungus. The synthesized peptides were tested for their antimicrobial activity against an ESKAPE pathogen panel, where peptide 3 exhibited equipotent MIC and potent synergistic action along with gentamicin against Staphylococcus aureus and Enterococcus clinical isolates. This combination was also able to repotentiate gentamicin against NRS119, a gentamicin‐resistant MRSA. Molecular dynamics study and free energy calculations provided insights to membrane disruptive properties of AMP action, which assisted gentamicin pass through the lipid–water interface.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Indian Institute of Technology Kanpur, Kanpur, India.
- Department of Microbiology, CSIR-Central Drug Research Institute, Lucknow, India.
- AcSIR: Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India.
- Center for Nanosciences, Centre for Environmental Science and Engineering, Mehta Center for Engineering in Medicine, Gangwal School of Medical Sciences and Technology, Centre for Environmental Science and Engineering, I…
ORCID-Profile: Shalini Singh, Grace Kaul, Sidharth Chopra, Sandeep Verma
Förderung
- This research was supported by Center of Excellence in Antimicrobial Resistance, Department of Science and Technology, Ministry of Science and Technology, Indi…
Zitieren
APA
Singh, S., Kaul, G., Shukla, M., Akhir, A., Tripathi, S., Gupta, A., Bormon, R., Nair, N. N., Chopra, S., & Verma, S. (2025). Linear Antimicrobial Peptide, Containing a Diindolyl Methane Unnatural Amino Acid, Potentiates Gentamicin Against Methicillin‐Resistant Staphylococcus aureus. Drug Development Research. https://doi.org/10.1002/ddr.70070
Vancouver
Singh S, Kaul G, Shukla M, Akhir A, Tripathi S, Gupta A, et al. Linear Antimicrobial Peptide, Containing a Diindolyl Methane Unnatural Amino Acid, Potentiates Gentamicin Against Methicillin‐Resistant Staphylococcus aureus. Drug Development Research. 2025. doi:10.1002/ddr.70070
BibTeX
@article{Singh2025,
author = {Singh, Shalini and Kaul, Grace and Shukla, Manjulika and Akhir, Abdul and Tripathi, Shubhandra and Gupta, Abhinav and Bormon, Rakhi and Nair, Nisanth N and Chopra, Sidharth and Verma, Sandeep},
title = {Linear Antimicrobial Peptide, Containing a Diindolyl Methane Unnatural Amino Acid, Potentiates Gentamicin Against Methicillin‐Resistant Staphylococcus aureus},
journal = {Drug Development Research},
year = {2025},
doi = {10.1002/ddr.70070}
}
EUVIMED